Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
MicroRNAs | 121 | 2024 | 3805 | 13.850 |
Why?
|
Caenorhabditis elegans | 57 | 2023 | 1462 | 6.900 |
Why?
|
Caenorhabditis elegans Proteins | 35 | 2023 | 875 | 5.720 |
Why?
|
RNA, Untranslated | 12 | 2023 | 457 | 3.260 |
Why?
|
Oncogenes | 14 | 2021 | 1235 | 2.510 |
Why?
|
3' Untranslated Regions | 15 | 2024 | 515 | 2.310 |
Why?
|
Gene Expression Regulation, Neoplastic | 30 | 2024 | 8635 | 2.230 |
Why?
|
ras Proteins | 10 | 2014 | 1058 | 1.780 |
Why?
|
RNA-Binding Proteins | 12 | 2022 | 1885 | 1.770 |
Why?
|
Neoplasms | 32 | 2023 | 22386 | 1.750 |
Why?
|
Longevity | 12 | 2023 | 1077 | 1.570 |
Why?
|
RNA, Neoplasm | 5 | 2020 | 751 | 1.510 |
Why?
|
Genes, Tumor Suppressor | 7 | 2021 | 1064 | 1.260 |
Why?
|
Aging | 11 | 2024 | 8761 | 1.170 |
Why?
|
Adenosine Deaminase | 4 | 2022 | 253 | 1.160 |
Why?
|
RNA, Helminth | 8 | 2014 | 59 | 1.120 |
Why?
|
Gene Expression Regulation | 23 | 2021 | 11930 | 1.120 |
Why?
|
RNA Editing | 4 | 2022 | 149 | 1.120 |
Why?
|
Transcription Factors | 23 | 2023 | 12174 | 1.110 |
Why?
|
Animals | 117 | 2024 | 169418 | 1.070 |
Why?
|
Genes, Helminth | 11 | 2010 | 146 | 1.050 |
Why?
|
Gene Expression Regulation, Developmental | 19 | 2017 | 3612 | 1.020 |
Why?
|
Neoplasms, Glandular and Epithelial | 3 | 2015 | 489 | 0.990 |
Why?
|
RNA, Small Untranslated | 2 | 2018 | 77 | 0.940 |
Why?
|
Body Patterning | 7 | 2009 | 633 | 0.910 |
Why?
|
Peptide Nucleic Acids | 5 | 2023 | 27 | 0.900 |
Why?
|
Proto-Oncogene Proteins | 7 | 2018 | 4534 | 0.850 |
Why?
|
Karyopherins | 1 | 2023 | 134 | 0.840 |
Why?
|
Adenylosuccinate Lyase | 1 | 2022 | 4 | 0.830 |
Why?
|
S-Phase Kinase-Associated Proteins | 1 | 2021 | 89 | 0.760 |
Why?
|
Larva | 6 | 2017 | 514 | 0.760 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2023 | 435 | 0.740 |
Why?
|
Lung Neoplasms | 15 | 2023 | 13589 | 0.730 |
Why?
|
Cell Line, Tumor | 29 | 2024 | 17149 | 0.730 |
Why?
|
Oligonucleotides, Antisense | 3 | 2023 | 462 | 0.700 |
Why?
|
DNA-Binding Proteins | 12 | 2023 | 9623 | 0.700 |
Why?
|
RNA Splicing | 3 | 2021 | 906 | 0.690 |
Why?
|
RNA, Small Interfering | 8 | 2018 | 3437 | 0.690 |
Why?
|
Cell Proliferation | 14 | 2021 | 10494 | 0.660 |
Why?
|
Lymphoma | 4 | 2022 | 1907 | 0.660 |
Why?
|
Radiation Tolerance | 3 | 2013 | 478 | 0.660 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2020 | 1427 | 0.650 |
Why?
|
Transcription, Genetic | 13 | 2021 | 7599 | 0.640 |
Why?
|
RNA, Transfer | 3 | 2021 | 284 | 0.640 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 8 | 2016 | 1766 | 0.640 |
Why?
|
Cell Hypoxia | 2 | 2019 | 661 | 0.620 |
Why?
|
Herpesvirus 4, Human | 2 | 2018 | 1081 | 0.620 |
Why?
|
Sarcoma, Kaposi | 1 | 2021 | 374 | 0.610 |
Why?
|
Cell Transformation, Neoplastic | 6 | 2021 | 2847 | 0.600 |
Why?
|
Citric Acid Cycle | 1 | 2019 | 234 | 0.590 |
Why?
|
Oligonucleotides | 1 | 2020 | 564 | 0.580 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 2018 | 158 | 0.570 |
Why?
|
Gene Silencing | 4 | 2021 | 1503 | 0.570 |
Why?
|
Repressor Proteins | 8 | 2019 | 2987 | 0.570 |
Why?
|
RNA Processing, Post-Transcriptional | 5 | 2021 | 393 | 0.570 |
Why?
|
Oligodeoxyribonucleotides, Antisense | 1 | 2017 | 57 | 0.560 |
Why?
|
Cytomegalovirus Retinitis | 1 | 2017 | 56 | 0.550 |
Why?
|
Down-Regulation | 8 | 2019 | 2944 | 0.550 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2020 | 2331 | 0.540 |
Why?
|
RNA | 4 | 2023 | 2727 | 0.540 |
Why?
|
Gene Expression Profiling | 13 | 2024 | 9507 | 0.530 |
Why?
|
Liver Neoplasms | 3 | 2020 | 4362 | 0.520 |
Why?
|
Genes, ras | 3 | 2014 | 666 | 0.520 |
Why?
|
Base Sequence | 15 | 2016 | 12428 | 0.500 |
Why?
|
RNA Interference | 9 | 2021 | 2832 | 0.480 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2018 | 727 | 0.470 |
Why?
|
Stomach Neoplasms | 2 | 2024 | 1484 | 0.470 |
Why?
|
Humans | 110 | 2024 | 768451 | 0.470 |
Why?
|
Mice | 32 | 2024 | 82045 | 0.470 |
Why?
|
Epigenesis, Genetic | 6 | 2021 | 3826 | 0.460 |
Why?
|
Cell Differentiation | 8 | 2021 | 11674 | 0.460 |
Why?
|
Toll-Like Receptor 8 | 1 | 2014 | 98 | 0.450 |
Why?
|
Liver Cirrhosis | 1 | 2024 | 1950 | 0.450 |
Why?
|
Transcriptional Activation | 4 | 2017 | 1751 | 0.440 |
Why?
|
Toll-Like Receptor 7 | 1 | 2014 | 169 | 0.440 |
Why?
|
Promoter Regions, Genetic | 10 | 2021 | 5803 | 0.430 |
Why?
|
Antisense Elements (Genetics) | 1 | 2013 | 37 | 0.430 |
Why?
|
Animals, Genetically Modified | 9 | 2018 | 1563 | 0.430 |
Why?
|
src-Family Kinases | 1 | 2015 | 539 | 0.420 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 2016 | 792 | 0.410 |
Why?
|
Introns | 3 | 2018 | 970 | 0.410 |
Why?
|
Axons | 2 | 2011 | 1678 | 0.410 |
Why?
|
Radiation, Ionizing | 1 | 2013 | 252 | 0.400 |
Why?
|
Nanoparticles | 4 | 2022 | 1986 | 0.390 |
Why?
|
RNA, Messenger | 8 | 2024 | 12813 | 0.390 |
Why?
|
Trans-Activators | 3 | 2014 | 2858 | 0.390 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2018 | 616 | 0.390 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2020 | 1905 | 0.380 |
Why?
|
Neoplastic Stem Cells | 3 | 2021 | 1357 | 0.380 |
Why?
|
Ovarian Neoplasms | 4 | 2014 | 4906 | 0.380 |
Why?
|
POU Domain Factors | 1 | 2011 | 47 | 0.380 |
Why?
|
Viral Proteins | 1 | 2018 | 1803 | 0.370 |
Why?
|
Casein Kinase Ialpha | 1 | 2010 | 26 | 0.370 |
Why?
|
Conserved Sequence | 7 | 2015 | 1164 | 0.360 |
Why?
|
Molecular Sequence Data | 14 | 2015 | 17647 | 0.360 |
Why?
|
Emulsions | 1 | 2011 | 152 | 0.360 |
Why?
|
Molecular Targeted Therapy | 3 | 2020 | 2834 | 0.360 |
Why?
|
Stem Cells | 4 | 2014 | 3538 | 0.350 |
Why?
|
Pancreatic Neoplasms | 4 | 2024 | 5442 | 0.350 |
Why?
|
Carcinoma, Pancreatic Ductal | 4 | 2024 | 1755 | 0.350 |
Why?
|
Mice, Nude | 5 | 2021 | 3635 | 0.350 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 5 | 2023 | 5426 | 0.340 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2010 | 99 | 0.340 |
Why?
|
Helminth Proteins | 3 | 2007 | 172 | 0.340 |
Why?
|
Genetic Vectors | 5 | 2019 | 3417 | 0.340 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2023 | 380 | 0.340 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2023 | 2964 | 0.330 |
Why?
|
Ribonuclease III | 3 | 2017 | 270 | 0.330 |
Why?
|
Methyltransferases | 3 | 2023 | 375 | 0.320 |
Why?
|
Mutation | 19 | 2024 | 30243 | 0.320 |
Why?
|
Drug Delivery Systems | 2 | 2024 | 2238 | 0.320 |
Why?
|
Antineoplastic Agents | 4 | 2020 | 13708 | 0.320 |
Why?
|
Disease Models, Animal | 10 | 2021 | 18388 | 0.320 |
Why?
|
Microscopy, Fluorescence | 1 | 2016 | 2640 | 0.320 |
Why?
|
Neural Tube | 1 | 2008 | 48 | 0.310 |
Why?
|
Ribosomal Proteins | 2 | 2009 | 371 | 0.310 |
Why?
|
Binding Sites | 8 | 2015 | 6030 | 0.310 |
Why?
|
Biological Evolution | 3 | 2007 | 1081 | 0.310 |
Why?
|
Adenocarcinoma | 2 | 2019 | 6400 | 0.310 |
Why?
|
Open Reading Frames | 1 | 2012 | 812 | 0.310 |
Why?
|
RNA-Induced Silencing Complex | 1 | 2008 | 52 | 0.310 |
Why?
|
Microarray Analysis | 3 | 2007 | 752 | 0.300 |
Why?
|
Phylogeny | 5 | 2021 | 2846 | 0.300 |
Why?
|
Hematologic Neoplasms | 1 | 2020 | 1905 | 0.300 |
Why?
|
Tumor Microenvironment | 4 | 2024 | 3939 | 0.300 |
Why?
|
Neurodegenerative Diseases | 1 | 2017 | 1095 | 0.290 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2021 | 3619 | 0.290 |
Why?
|
Medical Oncology | 1 | 2019 | 2347 | 0.290 |
Why?
|
Alleles | 6 | 2021 | 6890 | 0.280 |
Why?
|
Stromal Cells | 2 | 2024 | 1335 | 0.280 |
Why?
|
Endoribonucleases | 1 | 2008 | 229 | 0.280 |
Why?
|
Clinical Trials, Phase I as Topic | 2 | 2020 | 330 | 0.280 |
Why?
|
Stress, Physiological | 2 | 2011 | 1409 | 0.280 |
Why?
|
Chromosome Mapping | 1 | 2015 | 4622 | 0.270 |
Why?
|
Cytoplasmic Structures | 1 | 2006 | 21 | 0.270 |
Why?
|
Lipids | 2 | 2023 | 3346 | 0.270 |
Why?
|
Membrane Proteins | 2 | 2017 | 7895 | 0.270 |
Why?
|
RNA, Double-Stranded | 2 | 2022 | 292 | 0.270 |
Why?
|
Protein Biosynthesis | 5 | 2018 | 2096 | 0.270 |
Why?
|
Genome, Helminth | 3 | 2010 | 15 | 0.260 |
Why?
|
Cell Cycle | 2 | 2012 | 2942 | 0.260 |
Why?
|
Disease Management | 1 | 2017 | 2533 | 0.260 |
Why?
|
Ribonucleoproteins | 1 | 2008 | 360 | 0.260 |
Why?
|
Clinical Trials, Phase II as Topic | 2 | 2020 | 637 | 0.260 |
Why?
|
DEAD-box RNA Helicases | 1 | 2008 | 384 | 0.250 |
Why?
|
Nuclear Proteins | 6 | 2023 | 5808 | 0.250 |
Why?
|
Embryonic Development | 2 | 2024 | 722 | 0.250 |
Why?
|
Casein Kinase Idelta | 1 | 2005 | 15 | 0.250 |
Why?
|
Motor Neurons | 1 | 2010 | 872 | 0.240 |
Why?
|
Immunotherapy | 3 | 2024 | 4728 | 0.240 |
Why?
|
Gene Regulatory Networks | 6 | 2023 | 1755 | 0.240 |
Why?
|
Forkhead Transcription Factors | 2 | 2023 | 1625 | 0.240 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2014 | 16029 | 0.240 |
Why?
|
Models, Genetic | 7 | 2018 | 3442 | 0.240 |
Why?
|
Tumor Cells, Cultured | 4 | 2021 | 6135 | 0.230 |
Why?
|
Cell Adhesion Molecules | 1 | 2010 | 1615 | 0.230 |
Why?
|
Receptors, Immunologic | 1 | 2010 | 1415 | 0.230 |
Why?
|
Membrane Glycoproteins | 1 | 2014 | 3713 | 0.220 |
Why?
|
Genes, Reporter | 4 | 2016 | 1525 | 0.220 |
Why?
|
Protein Kinases | 1 | 2010 | 1608 | 0.220 |
Why?
|
Lymphoma, B-Cell | 1 | 2010 | 945 | 0.220 |
Why?
|
Giant Cells | 1 | 2023 | 188 | 0.210 |
Why?
|
Coculture Techniques | 2 | 2024 | 1343 | 0.210 |
Why?
|
Cholesterol | 1 | 2012 | 2910 | 0.210 |
Why?
|
Embryonic Stem Cells | 1 | 2010 | 1249 | 0.210 |
Why?
|
Chromatin | 4 | 2023 | 2969 | 0.200 |
Why?
|
RNA, Small Cytoplasmic | 1 | 2002 | 17 | 0.200 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2024 | 5342 | 0.200 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2023 | 432 | 0.200 |
Why?
|
Gene Expression | 4 | 2021 | 7605 | 0.200 |
Why?
|
Nucleic Acids | 1 | 2024 | 190 | 0.200 |
Why?
|
Sequence Alignment | 3 | 2011 | 2184 | 0.200 |
Why?
|
Nucleic Acid Conformation | 3 | 2018 | 899 | 0.190 |
Why?
|
Homeodomain Proteins | 1 | 2011 | 2430 | 0.190 |
Why?
|
Feedback, Physiological | 2 | 2017 | 480 | 0.190 |
Why?
|
RNA Precursors | 2 | 2018 | 197 | 0.190 |
Why?
|
tRNA Methyltransferases | 1 | 2021 | 50 | 0.190 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 3 | 2014 | 863 | 0.190 |
Why?
|
NF-kappa B | 1 | 2010 | 2491 | 0.190 |
Why?
|
Models, Biological | 6 | 2021 | 9505 | 0.190 |
Why?
|
Up-Regulation | 4 | 2018 | 4138 | 0.190 |
Why?
|
Tumor Escape | 1 | 2024 | 374 | 0.190 |
Why?
|
Signal Transduction | 9 | 2017 | 23638 | 0.190 |
Why?
|
Cell Line | 5 | 2022 | 15609 | 0.180 |
Why?
|
Polymerase Chain Reaction | 3 | 2016 | 6091 | 0.180 |
Why?
|
Enhancer Elements, Genetic | 4 | 2021 | 1368 | 0.180 |
Why?
|
CDC2 Protein Kinase | 1 | 2021 | 212 | 0.180 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2017 | 2751 | 0.170 |
Why?
|
Eukaryotic Initiation Factor-3 | 2 | 2018 | 48 | 0.170 |
Why?
|
Reactive Oxygen Species | 2 | 2022 | 2150 | 0.170 |
Why?
|
Zinc Fingers | 2 | 2000 | 577 | 0.170 |
Why?
|
Embryo, Mammalian | 1 | 2005 | 1674 | 0.170 |
Why?
|
Herpesvirus 8, Human | 1 | 2021 | 256 | 0.170 |
Why?
|
Growth | 2 | 1998 | 366 | 0.170 |
Why?
|
Evolution, Molecular | 2 | 2010 | 1897 | 0.160 |
Why?
|
Hep G2 Cells | 1 | 2020 | 379 | 0.160 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2021 | 249 | 0.160 |
Why?
|
Purines | 1 | 2022 | 614 | 0.160 |
Why?
|
Repetitive Sequences, Amino Acid | 1 | 1998 | 91 | 0.160 |
Why?
|
HeLa Cells | 4 | 2014 | 3090 | 0.160 |
Why?
|
RNA, Transfer, Leu | 1 | 2018 | 13 | 0.160 |
Why?
|
RNA Stability | 1 | 2020 | 322 | 0.150 |
Why?
|
Protein Binding | 3 | 2020 | 9376 | 0.150 |
Why?
|
Histones | 5 | 2021 | 2595 | 0.150 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2020 | 452 | 0.150 |
Why?
|
Oxycodone | 1 | 2019 | 142 | 0.150 |
Why?
|
Drosophila Proteins | 2 | 2007 | 1712 | 0.150 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2021 | 342 | 0.150 |
Why?
|
Congresses as Topic | 1 | 2023 | 810 | 0.150 |
Why?
|
Disease Progression | 5 | 2021 | 13655 | 0.150 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 4417 | 0.140 |
Why?
|
Zebrafish | 2 | 2024 | 3038 | 0.140 |
Why?
|
Paraffin Embedding | 1 | 2018 | 306 | 0.140 |
Why?
|
Azacitidine | 1 | 2019 | 336 | 0.140 |
Why?
|
Thyroid Neoplasms | 2 | 2021 | 2360 | 0.140 |
Why?
|
Cell Communication | 1 | 2024 | 1662 | 0.140 |
Why?
|
Adenosine | 1 | 2022 | 816 | 0.140 |
Why?
|
Phenotype | 4 | 2009 | 16712 | 0.140 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 2009 | 1056 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 5 | 2015 | 18048 | 0.140 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2012 | 352 | 0.140 |
Why?
|
Formaldehyde | 1 | 2018 | 361 | 0.140 |
Why?
|
Nucleus Accumbens | 1 | 2019 | 372 | 0.130 |
Why?
|
Regulatory Elements, Transcriptional | 2 | 2009 | 182 | 0.130 |
Why?
|
Fibroblasts | 2 | 2024 | 4180 | 0.130 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2021 | 733 | 0.130 |
Why?
|
Adenoviridae | 2 | 2012 | 1098 | 0.130 |
Why?
|
Frontal Lobe | 1 | 2022 | 1427 | 0.130 |
Why?
|
Sequence Deletion | 1 | 2020 | 1497 | 0.130 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2017 | 330 | 0.130 |
Why?
|
Quantitative Trait Loci | 1 | 2024 | 2127 | 0.130 |
Why?
|
Multienzyme Complexes | 1 | 1998 | 666 | 0.120 |
Why?
|
Neoplasm Invasiveness | 3 | 2021 | 3637 | 0.120 |
Why?
|
Point Mutation | 1 | 2020 | 1596 | 0.120 |
Why?
|
Drug Design | 1 | 2020 | 1050 | 0.120 |
Why?
|
DNA Primers | 2 | 2012 | 2826 | 0.120 |
Why?
|
Ribosomes | 1 | 2018 | 500 | 0.120 |
Why?
|
Mice, Transgenic | 3 | 2020 | 9558 | 0.120 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2018 | 3794 | 0.120 |
Why?
|
Base Pairing | 2 | 2023 | 139 | 0.110 |
Why?
|
Acids | 1 | 2014 | 125 | 0.110 |
Why?
|
DNA | 3 | 2023 | 7213 | 0.110 |
Why?
|
Photochemotherapy | 1 | 2020 | 832 | 0.110 |
Why?
|
Insulin | 2 | 2023 | 6606 | 0.110 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2017 | 656 | 0.110 |
Why?
|
Behavior, Addictive | 1 | 2019 | 467 | 0.110 |
Why?
|
Transfection | 3 | 2020 | 5767 | 0.110 |
Why?
|
Circadian Rhythm | 1 | 2005 | 2585 | 0.110 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2011 | 1943 | 0.110 |
Why?
|
Apoptosis | 3 | 2021 | 9526 | 0.110 |
Why?
|
Cell Membrane Permeability | 1 | 2014 | 574 | 0.100 |
Why?
|
Nanotechnology | 1 | 2018 | 714 | 0.100 |
Why?
|
Cell Separation | 1 | 2018 | 1726 | 0.100 |
Why?
|
Hydrogels | 1 | 2018 | 745 | 0.100 |
Why?
|
DNA Methylation | 3 | 2021 | 4421 | 0.100 |
Why?
|
Mucin-1 | 1 | 2017 | 538 | 0.100 |
Why?
|
Drug Stability | 1 | 2013 | 291 | 0.100 |
Why?
|
Molecular Sequence Annotation | 2 | 2014 | 526 | 0.100 |
Why?
|
Clinical Trials as Topic | 2 | 2019 | 8051 | 0.100 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4586 | 0.100 |
Why?
|
Gene Library | 1 | 2015 | 1064 | 0.100 |
Why?
|
Gene Knockdown Techniques | 2 | 2021 | 1608 | 0.100 |
Why?
|
Mice, Inbred C57BL | 3 | 2024 | 22365 | 0.100 |
Why?
|
Genes, Switch | 2 | 2003 | 48 | 0.100 |
Why?
|
Neointima | 1 | 2012 | 133 | 0.100 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2017 | 1115 | 0.100 |
Why?
|
HEK293 Cells | 1 | 2021 | 4294 | 0.100 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2016 | 687 | 0.090 |
Why?
|
Cancer Vaccines | 1 | 2019 | 1044 | 0.090 |
Why?
|
Female | 17 | 2024 | 396943 | 0.090 |
Why?
|
Fluorescence | 1 | 2013 | 760 | 0.090 |
Why?
|
Genetic Markers | 3 | 2011 | 2604 | 0.090 |
Why?
|
Drug Synergism | 1 | 2015 | 1765 | 0.090 |
Why?
|
Lymphoid Tissue | 1 | 2012 | 446 | 0.090 |
Why?
|
Amino Acid Sequence | 4 | 2005 | 13452 | 0.090 |
Why?
|
Liver Regeneration | 1 | 2012 | 214 | 0.090 |
Why?
|
Growth and Development | 1 | 2010 | 46 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2021 | 4642 | 0.090 |
Why?
|
Doxycycline | 1 | 2012 | 348 | 0.090 |
Why?
|
Cell Lineage | 3 | 2021 | 2575 | 0.090 |
Why?
|
Endothelium | 1 | 2012 | 768 | 0.090 |
Why?
|
Cyclin D1 | 1 | 2012 | 454 | 0.090 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2014 | 2488 | 0.080 |
Why?
|
Proteomics | 1 | 2023 | 3901 | 0.080 |
Why?
|
RNA Polymerase II | 1 | 2014 | 547 | 0.080 |
Why?
|
Time Factors | 6 | 2009 | 40271 | 0.080 |
Why?
|
Sequence Analysis, RNA | 3 | 2014 | 2039 | 0.080 |
Why?
|
DNA Helicases | 1 | 2014 | 853 | 0.080 |
Why?
|
Cell Dedifferentiation | 1 | 2010 | 124 | 0.080 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2009 | 293 | 0.080 |
Why?
|
Cloning, Molecular | 3 | 2014 | 4175 | 0.080 |
Why?
|
Genes, Lethal | 1 | 2008 | 223 | 0.080 |
Why?
|
Dermis | 1 | 2009 | 204 | 0.080 |
Why?
|
Estrogens | 1 | 2015 | 1531 | 0.080 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2013 | 614 | 0.080 |
Why?
|
Disorders of Sex Development | 1 | 2009 | 129 | 0.080 |
Why?
|
Cytokines | 2 | 2024 | 7449 | 0.070 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 621 | 0.070 |
Why?
|
Chromosomes | 1 | 2010 | 579 | 0.070 |
Why?
|
cdc25 Phosphatases | 1 | 2007 | 60 | 0.070 |
Why?
|
Oxidative Stress | 2 | 2016 | 3145 | 0.070 |
Why?
|
Cell Survival | 2 | 2021 | 5801 | 0.070 |
Why?
|
Genes, BRCA1 | 1 | 2011 | 755 | 0.070 |
Why?
|
Fibroblast Growth Factors | 1 | 2012 | 873 | 0.070 |
Why?
|
Cell Growth Processes | 1 | 2007 | 383 | 0.070 |
Why?
|
Drosophila melanogaster | 2 | 2014 | 1725 | 0.070 |
Why?
|
Wnt Proteins | 1 | 2010 | 724 | 0.070 |
Why?
|
Amino Acid Motifs | 1 | 2009 | 930 | 0.070 |
Why?
|
Cell Division | 2 | 2010 | 4479 | 0.070 |
Why?
|
Gene Components | 1 | 2005 | 27 | 0.070 |
Why?
|
Administration, Intranasal | 1 | 2008 | 485 | 0.070 |
Why?
|
Liver | 2 | 2012 | 7575 | 0.070 |
Why?
|
DNA Damage | 1 | 2016 | 2461 | 0.060 |
Why?
|
Environment | 1 | 2012 | 1126 | 0.060 |
Why?
|
Lentivirus | 1 | 2009 | 519 | 0.060 |
Why?
|
Cell Compartmentation | 1 | 2006 | 383 | 0.060 |
Why?
|
beta Catenin | 1 | 2010 | 1048 | 0.060 |
Why?
|
RNA Helicases | 1 | 2006 | 144 | 0.060 |
Why?
|
Neurons, Afferent | 1 | 2008 | 498 | 0.060 |
Why?
|
Genetic Variation | 3 | 2015 | 6610 | 0.060 |
Why?
|
Cell Membrane | 1 | 2014 | 3664 | 0.060 |
Why?
|
Prognosis | 3 | 2018 | 30028 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2011 | 2362 | 0.060 |
Why?
|
Cytoskeletal Proteins | 1 | 2010 | 1337 | 0.060 |
Why?
|
Acetylgalactosamine | 1 | 2024 | 41 | 0.060 |
Why?
|
Hot Temperature | 1 | 2011 | 1439 | 0.060 |
Why?
|
Metabolism | 1 | 2006 | 193 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 2003 | 0.060 |
Why?
|
Blotting, Western | 1 | 2012 | 5042 | 0.060 |
Why?
|
Pancreatic Stellate Cells | 1 | 2024 | 28 | 0.060 |
Why?
|
Haplotypes | 1 | 2011 | 2725 | 0.060 |
Why?
|
Blotting, Northern | 1 | 2005 | 1553 | 0.060 |
Why?
|
Proteins | 1 | 1998 | 6008 | 0.060 |
Why?
|
Sequence Analysis, DNA | 2 | 2005 | 4780 | 0.050 |
Why?
|
Lipid Metabolism | 1 | 2012 | 1898 | 0.050 |
Why?
|
Organogenesis | 1 | 2005 | 214 | 0.050 |
Why?
|
Pilot Projects | 1 | 2016 | 8730 | 0.050 |
Why?
|
Muscles | 1 | 2008 | 1582 | 0.050 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2019 | 3623 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10784 | 0.050 |
Why?
|
Male | 8 | 2024 | 364781 | 0.050 |
Why?
|
Homeostasis | 1 | 2014 | 3351 | 0.050 |
Why?
|
Pharynx | 1 | 2005 | 436 | 0.050 |
Why?
|
Equipment Failure Analysis | 1 | 2004 | 848 | 0.050 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2024 | 333 | 0.050 |
Why?
|
Guanosine | 1 | 2021 | 43 | 0.050 |
Why?
|
In Situ Hybridization | 1 | 2005 | 1906 | 0.050 |
Why?
|
Flow Cytometry | 1 | 2012 | 5904 | 0.050 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2024 | 507 | 0.050 |
Why?
|
Genome, Human | 2 | 2021 | 4453 | 0.050 |
Why?
|
Brain | 2 | 2022 | 27438 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2011 | 4931 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10273 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2014 | 22293 | 0.040 |
Why?
|
Extremities | 1 | 2005 | 870 | 0.040 |
Why?
|
Breast Neoplasms | 4 | 2024 | 21156 | 0.040 |
Why?
|
Isoenzymes | 1 | 2005 | 1685 | 0.040 |
Why?
|
Phenylthiohydantoin | 1 | 2021 | 208 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14766 | 0.040 |
Why?
|
SOXB1 Transcription Factors | 1 | 2021 | 286 | 0.040 |
Why?
|
Lymphocytes | 1 | 2008 | 2611 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2016 | 5709 | 0.040 |
Why?
|
Systems Biology | 1 | 2023 | 481 | 0.040 |
Why?
|
Cell Nucleus | 2 | 2021 | 2889 | 0.040 |
Why?
|
Small Molecule Libraries | 1 | 2024 | 746 | 0.040 |
Why?
|
Cyclization | 1 | 2018 | 59 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2021 | 11206 | 0.040 |
Why?
|
Polyribosomes | 1 | 2018 | 109 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11138 | 0.040 |
Why?
|
Cell Movement | 2 | 2021 | 5223 | 0.040 |
Why?
|
Methylation | 1 | 2021 | 1077 | 0.040 |
Why?
|
Microinjections | 1 | 2019 | 322 | 0.040 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2010 | 1890 | 0.040 |
Why?
|
Self Administration | 1 | 2019 | 387 | 0.040 |
Why?
|
Genome | 1 | 2006 | 1749 | 0.040 |
Why?
|
Mixed Function Oxygenases | 1 | 1998 | 265 | 0.040 |
Why?
|
Exons | 1 | 2003 | 2392 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 1839 | 0.030 |
Why?
|
Virus Activation | 1 | 2019 | 322 | 0.030 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2022 | 1152 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2021 | 1706 | 0.030 |
Why?
|
Multigene Family | 1 | 2000 | 1081 | 0.030 |
Why?
|
Receptors, Dopamine D2 | 1 | 2019 | 486 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2024 | 1738 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2012 | 4984 | 0.030 |
Why?
|
Equipment Design | 1 | 2004 | 3530 | 0.030 |
Why?
|
Nitriles | 1 | 2021 | 984 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2017 | 287 | 0.030 |
Why?
|
Retroviridae | 1 | 2019 | 850 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2007 | 4249 | 0.030 |
Why?
|
Computational Biology | 2 | 2023 | 3546 | 0.030 |
Why?
|
Mice, SCID | 1 | 2021 | 2633 | 0.030 |
Why?
|
Benzamides | 1 | 2021 | 1381 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2000 | 2298 | 0.030 |
Why?
|
Intestines | 1 | 2005 | 1912 | 0.030 |
Why?
|
Protein Transport | 1 | 2021 | 1963 | 0.030 |
Why?
|
Organoids | 1 | 2021 | 749 | 0.030 |
Why?
|
Receptors, Androgen | 1 | 2021 | 1084 | 0.030 |
Why?
|
B-Lymphocytes | 1 | 2008 | 4781 | 0.030 |
Why?
|
Erythrocytes | 1 | 2024 | 2422 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2019 | 2017 | 0.030 |
Why?
|
Phosphotransferases | 1 | 2016 | 303 | 0.030 |
Why?
|
Pupa | 1 | 2014 | 42 | 0.030 |
Why?
|
Lung | 2 | 2018 | 10090 | 0.030 |
Why?
|
Software | 1 | 2009 | 4463 | 0.030 |
Why?
|
Particle Size | 1 | 2018 | 1654 | 0.030 |
Why?
|
Dependovirus | 1 | 2019 | 720 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2003 | 2819 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2005 | 3048 | 0.030 |
Why?
|
Carcinoma | 1 | 2005 | 2341 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2008 | 14480 | 0.030 |
Why?
|
Immunomodulation | 1 | 2017 | 550 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1561 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2008 | 19041 | 0.030 |
Why?
|
Androgen Antagonists | 1 | 2021 | 1418 | 0.030 |
Why?
|
Melanoma | 1 | 2011 | 5740 | 0.030 |
Why?
|
Esters | 1 | 2013 | 212 | 0.030 |
Why?
|
Catalytic Domain | 1 | 2014 | 709 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2016 | 59680 | 0.020 |
Why?
|
Caenorhabditis | 1 | 2010 | 39 | 0.020 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2015 | 628 | 0.020 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2014 | 633 | 0.020 |
Why?
|
Estrogen Replacement Therapy | 1 | 2015 | 1209 | 0.020 |
Why?
|
Neurons | 1 | 2008 | 9504 | 0.020 |
Why?
|
Vasculitis | 1 | 2012 | 524 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2019 | 2757 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2731 | 0.020 |
Why?
|
Alzheimer Disease | 1 | 2008 | 8721 | 0.020 |
Why?
|
Aged | 2 | 2016 | 171520 | 0.020 |
Why?
|
Carrier Proteins | 1 | 1998 | 4948 | 0.020 |
Why?
|
Phosphorylation | 1 | 2016 | 8332 | 0.010 |
Why?
|
Cohort Studies | 2 | 2021 | 41797 | 0.010 |
Why?
|
Middle Aged | 2 | 2016 | 223418 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2012 | 6241 | 0.010 |
Why?
|
Rats | 1 | 2019 | 23839 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2014 | 3665 | 0.010 |
Why?
|
DNA, Helminth | 1 | 2000 | 35 | 0.010 |
Why?
|
Suppression, Genetic | 1 | 2000 | 190 | 0.010 |
Why?
|
Risk | 1 | 2008 | 9642 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2014 | 20231 | 0.010 |
Why?
|
Species Specificity | 1 | 2000 | 2422 | 0.010 |
Why?
|
Genomics | 1 | 2010 | 5909 | 0.010 |
Why?
|
Smoking | 1 | 2008 | 9099 | 0.010 |
Why?
|
Risk Factors | 1 | 2015 | 74915 | 0.000 |
Why?
|
Adult | 2 | 2010 | 223542 | 0.000 |
Why?
|